Recursion Pharmaceuticals’ latest earnings call struck a cautiously optimistic tone as management highlighted its first AI-enabled clinical proof-of-concept, major cost cuts, and an extended cash ...
08/27/2026 Scott Canna, M.D. Professor of Pediatrics, Physician in the department of Rheumatology and the Immune Dysregulation Program, Children's Hospital of Philadelphia 09/03/2026 Teruyuki Sano, Ph ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results